Liu Z - Search Results

1

A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8⁺ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H. Sun Z, et al. Among authors: liu z. Nat Commun. 2019 Aug 28;10(1):3874. doi: 10.1038/s41467-019-11782-w. Nat Commun. 2019. PMID: 31462678 Free PMC article.

2

CTLA-4 Limits Anti-CD20-Mediated Tumor Regression.

Ren Z, Guo J, Liao J, Luan Y, Liu Z, Sun Z, Liu X, Liang Y, Peng H, Fu YX. Ren Z, et al. Among authors: liu z, liu x. Clin Cancer Res. 2017 Jan 1;23(1):193-203. doi: 10.1158/1078-0432.CCR-16-0040. Epub 2016 Jun 27. Clin Cancer Res. 2017. PMID: 27354469 Free PMC article.

3

Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8⁺ T Cell Apoptosis.

Qiao J, Liu Z, Dong C, Luan Y, Zhang A, Moore C, Fu K, Peng J, Wang Y, Ren Z, Han C, Xu T, Fu YX. Qiao J, et al. Among authors: liu z. Cancer Cell. 2019 Jun 10;35(6):901-915.e4. doi: 10.1016/j.ccell.2019.05.005. Cancer Cell. 2019. PMID: 31185213 Free article.

4

Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8⁺ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H. Sun Z, et al. Among authors: liu z. Nat Commun. 2020 Apr 1;11(1):1716. doi: 10.1038/s41467-020-15532-1. Nat Commun. 2020. PMID: 32238807 Free PMC article.

5

A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy.

Hsu EJ, Cao X, Moon B, Bae J, Sun Z, Liu Z, Fu YX. Hsu EJ, et al. Among authors: liu z. Nat Commun. 2021 May 13;12(1):2768. doi: 10.1038/s41467-021-22980-w. Nat Commun. 2021. PMID: 33986267 Free PMC article.

6

Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity.

Feng Q, Liu Z, Yu X, Huang T, Chen J, Wang J, Wilhelm J, Li S, Song J, Li W, Sun Z, Sumer BD, Li B, Fu YX, Gao J. Feng Q, et al. Among authors: liu z. Nat Commun. 2022 Sep 6;13(1):4981. doi: 10.1038/s41467-022-32521-8. Nat Commun. 2022. PMID: 36068198 Free PMC article.

7

Adapting conventional cancer treatment for immunotherapy.

Qiao J, Liu Z, Fu YX. Qiao J, et al. Among authors: liu z. J Mol Med (Berl). 2016 May;94(5):489-95. doi: 10.1007/s00109-016-1393-4. Epub 2016 Feb 24. J Mol Med (Berl). 2016. PMID: 26910191 Review.

8

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance.

Li X, Liu Z, Zhang A, Han C, Shen A, Jiang L, Boothman DA, Qiao J, Wang Y, Huang X, Fu YX. Li X, et al. Among authors: liu z. Nat Commun. 2019 Jul 19;10(1):3251. doi: 10.1038/s41467-019-11238-1. Nat Commun. 2019. PMID: 31324798 Free PMC article.

9

Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis.

Rao L, Wu L, Liu Z, Tian R, Yu G, Zhou Z, Yang K, Xiong HG, Zhang A, Yu GT, Sun W, Xu H, Guo J, Li A, Chen H, Sun ZJ, Fu YX, Chen X. Rao L, et al. Among authors: liu z. Nat Commun. 2020 Sep 30;11(1):4909. doi: 10.1038/s41467-020-18626-y. Nat Commun. 2020. PMID: 32999291 Free PMC article.

10

Targeting innate sensing in the tumor microenvironment to improve immunotherapy.

Liu Z, Han C, Fu YX. Liu Z, et al. Cell Mol Immunol. 2020 Jan;17(1):13-26. doi: 10.1038/s41423-019-0341-y. Epub 2019 Dec 16. Cell Mol Immunol. 2020. PMID: 31844141 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89,197 results

Search Page

Filters